GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Shanghai Rendu Biotechnology Co Ltd (SHSE:688193) » Definitions » YoY EBITDA Growth

Shanghai Rendu Biotechnology Co (SHSE:688193) YoY EBITDA Growth : -82.35% (As of Mar. 2025)


View and export this data going back to 2022. Start your Free Trial

What is Shanghai Rendu Biotechnology Co YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Shanghai Rendu Biotechnology Co's YoY EBITDA Growth for the quarter that ended in Mar. 2025 was -82.35%.

Shanghai Rendu Biotechnology Co's EBITDA per Share for the three months ended in Mar. 2025 was ¥0.02.


Shanghai Rendu Biotechnology Co YoY EBITDA Growth Historical Data

The historical data trend for Shanghai Rendu Biotechnology Co's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Rendu Biotechnology Co YoY EBITDA Growth Chart

Shanghai Rendu Biotechnology Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
YoY EBITDA Growth
Get a 7-Day Free Trial 854.72 8.02 -60.12 -44.04 -90.82

Shanghai Rendu Biotechnology Co Quarterly Data
Dec18 Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 141.46 114.81 -52.94 -203.33 -82.35

Shanghai Rendu Biotechnology Co YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Shanghai Rendu Biotechnology Co's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (A: Dec. 2024 )
=(EBITDA per Share (A: Dec. 2024 )-EBITDA per Share (A: Dec. 2023 ))/ | EBITDA per Share (A: Dec. 2023 ) |
=(0.056-0.61)/ | 0.61 |
=-90.82 %

Shanghai Rendu Biotechnology Co's YoY EBITDA Growth for the quarter that ended in Mar. 2025 is calculated as:

YoY EBITDA Growth (Q: Mar. 2025 )
=(EBITDA per Share (Q: Mar. 2025 )-EBITDA per Share (Q: Mar. 2024 )) / | EBITDA per Share (Q: Mar. 2024 )) |
=(0.015-0.085)/ | 0.085 |
=-82.35 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Rendu Biotechnology Co YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Shanghai Rendu Biotechnology Co's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Rendu Biotechnology Co Business Description

Traded in Other Exchanges
N/A
Address
No. 528, Ruiqing Road, No. B, Building 15, East District, Zhangjiang Hi-Tech Park, Shanghai, CHN, 201201
Shanghai Rendu Biotechnology Co Ltd provides solutions for accurate diagnosis, effective prevention and control, as well as personalized diagnosis and treatment of pathogens in the areas of reproduction, respiration, digestion, blood, food, and environmental safety.

Shanghai Rendu Biotechnology Co Headlines

No Headlines